藥物食品分析期刊 - 期刊 - 衛生福利部食品藥物管理署 跳到主要內容區塊

專刊推廣 【發布日期:2020-01-15】 發布單位:

 

Volume 27 • Issue 2

Special Issue

April 2019

 

Mass Spectrometry for Clinical Diagnosis

 

Mass spectrometry has been applied in many biomedical researches including proteomics, metabolomics, cancer markers, microorganism diagnosis, and new born screening. To facilitate further development of mass spectrometry for clinical medicine, the Journal of Food and Drug Analysis (JFDA) published a special issue entitled “Mass Spectrometry for Clinical Diagnosis" in 2019. The objective of the special issue is to introduce recent advances of preclinical and clinical researches as well as regulatory perspectives by using modern mass spectrometry.

 
 
 

1

Analytical methods for cholesterol quantification

375-386

2

Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics

387-403

3

Current status of MALDI-TOF mass spectrometry in clinical microbiology

404-414

4

Rapid identification of herbal toxins using electrospray laser desorption ionization mass spectrometry for emergency care

415-427

5

Rapid detection and quantitation of drugs-of-abuse by wooden-tip electrospray ionization mass spectrometry

428-438

6

Using ambient mass spectrometry and LC-MS/MS for the rapid detection and identification of multiple illicit street drugs

439-450

7

Direct and rapid characterization of illicit drugs in adulterated samples using thermal desorption electrospray ionization mass spectrometry

451-459

8

Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers

460-474

9

Method development of immunoglobulin G purification from micro-volumes of human serum for untargeted and targeted proteomics-based antibody repertoire studies

475-482

10

Glycoproteomic identification of novel plasma biomarkers for oral cancer

483-493

11

Using gas chromatography and mass spectrometry to determine 25-hydroxyvitamin D levels for clinical assessment of vitamin D deficiency

494-501

12

Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS

502-509

13

Quantitation of serum 25(OH)D2 and 25(OH)D3 concentrations by liquid chromatography tandem mass spectrometry in patients with diabetes mellitus

510-517

14

Detection of BPDE-DNA adducts in human umbilical cord blood by LC-MS/MS analysis

518-525

15

Stability of glyoxal- and methylglyoxal-modified hemoglobin on dried blood spot cards as analyzed by nanoflow liquid chromatography tandem mass spectrometry

526-530

16

Complete mapping of disulfide linkages for etanercept products by multi-enzyme digestion coupled with LC-MS/MS using multi-fragmentations including CID and ETD

531-541

17

PON-1 carbamylation is enhanced in HDL of uremia patients

542-550

18

Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer's disease

551-564

19

Chemical isotope labeling liquid chromatography mass spectrometry for investigating acute dietary effects of cow milk consumption on human urine metabolome

565-574

20

Identification of bacteria in juice/lettuce using magnetic nanoparticles and selected reaction monitoring mass spectrometry

575-584

21

Exposure marker discovery of di-2(propylheptyl) phthalate using ultra-performance liquid chromatography-mass spectrometry and a rat model

585-594

22

Analysis of heterocyclic amines in meat products by liquid chromatography - Tandem mass spectrometry

595-602

23

Utilizing proteomic approach to identify nuclear translocation related serine kinase phosphorylation site of GNMT as downstream effector for benzo[a]pyrene

603-609

24

Blotting paper as a disposable tool for sampling chemical residues from skin surface

610-613